Position in STE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,005,608
+$9,110,342 QoQ
Shares Held
118,752
+65.2% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $703,036,151 across 14 Medical Devices names. STE ranks #9 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,512,160 | $230,226,360 | |
| 2 | NEOG |
Neogen Corp
|
9,333,261 | $83,906,016 | |
| 3 | HAE |
Haemonetics Corp
|
1,101,371 | $82,602,825 | |
| 4 | PRCT |
PROCEPT BioRobotics Corp
|
3,265,704 | $73,739,596 | |
| 5 | ALMR |
Alamar Biosciences, Inc.
|
2,202,597 | $59,668,352 | |
| 6 | TXG |
10x Genomics, Inc.
|
1,266,954 | $48,575,016 | |
| 7 | QDEL |
QuidelOrtho Corp
|
1,743,563 | $30,547,223 | |
| 8 | IRMD |
Iradimed Corp
|
318,680 | $30,453,060 |
All Filings in STE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,005,608 | 118,752 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,895,266 | 71,882 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,164,943 | 12,484 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $2,196,524 | 8,877 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,563,351 | 6,508 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $419,075 | 1,849 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $290,867 | 1,415 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||